This report is based on HIV surveillance data reported by 30 Member States of the European Union/European Economic Area (EU/EEA) (all except Germany) and AIDS data reported by 28 EU/EEA countries (all except Belgium, Germany and Sweden) for 2017. All countries annually report case-based data to the TESSy HIV/AIDS database in accordance with standard EU case definitions [4]. The database is jointly coordinated by ECDC and the WHO Regional Office for Europe.
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
This report focuses on data findings on the continuum of HIV care submitted by countries in Europe and Central Asia for the 2018 round of reporting on implementation of the Dublin Declaration on Partnership to Fight HIV & AIDS in Europe and Central Asia.
The HIV Estimates Accuracy Tool is an R-based application that uses statistical methods to allow for adjusted estimates from HIV surveillance data taking into account the issues of missing data and reporting delay. While it does not replace the knowledge of data analysis with adjustments, it is intended for routine application in surveillance as no complex programming skills are needed.
Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016, 29 EU/EEA countries reported 5 631 confirmed shigellosis cases.
Cases of salmonellosis and campylobacteriosis have remained stable over the past five years, although listeriosis is on the rise. In 2017, there was an average of 100 food- and waterborne outbreaks per week.
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance